Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis and high disease perception in the brain are more likely to respond to TNF ...
Adults with rheumatoid arthritis (RA) and high levels of pain activation in their brain responded better to the TNF inhibitor certolizumab pegol in a phase 3 trial. Randomized phase 3 trial at six ...
Checkpoint inhibitor therapies can be thought of as the molecular “brake release” for the immune system. These drugs eliminate the protein barriers that block the immune system from recognizing and ...
Development of a novel RNA-based fibroblast growth factor receptor response signature (FGFR-PRS) for use in patients with urothelial cancer (UC). Theranostic imaging and treatment of chemotherapy ...
Meloxicam/Rizatriptan Effective in Migraine Patients With Inadequate Response to Oral CGRP Inhibitor
Findings showed meloxicam/rizatriptan statistically significantly improved migraine treatment response compared with prior oral CGRP inhibitor treatment. Topline data were announced from a phase 3 ...
Cognitive control is a term used to describe the processes that enable us to think, feel, and act in flexible, goal-directed ways. Psychologists have been fascinated by the concept of cognitive ...
Clinical Trials Arena on MSN
InnoCare’s BTK inhibitor advances to Phase III in SLE
Within the 48-week treatment window, the Bruton’s tyrosine kinase (BTK) inhibitor triggered a 57.1% improvement in patients’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback